Synthesis of phenyloxyisobutyric acid derivatives and their antidiabetic activity in vitro

Yaoxue Xuebao

Volumn 41, Issue 2, 2006, Pages 108-114

  Zeng, Qing Le ^a,b   Wang, He Qing ^a   Luo, Huan ^c   Gao, Xiao Ping ^b   Liu, Zhong Rong ^b   Li, Bo Gang ^b   Wang, Feng Peng ^c   Zhao, Yu Fen ^a  

^a XIAMEN UNIVERSITY   (China)

^b Institute of Pharmacy   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

3T3 L1 adipocytes; Antidiabetic activity; GOD POD method; Insulin sensitizers; Phenyloxyisobutyric acid derivatives

Indexed keywords

ANTIDIABETIC AGENT; BUTYRIC ACID DERIVATIVE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ANIMAL; ARTICLE; CELL STRAIN 3T3; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; MOUSE; SYNTHESIS;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BUTYRIC ACIDS; HYPOGLYCEMIC AGENTS; INSULIN; MICE; MOLECULAR STRUCTURE; PPAR GAMMA;

EID: 33645579194     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Graul AI. Compendium of endocrine and metabolic drugs [J]. Drugs Fut, 2003,28:991-1046.
2. Tang L, Yang YS, Ji RY. Progress in studies on antidiabetic agents [J]. Acta Pharm Sin, 2001,36:711-715.
3. Huang Y, Zhang HB, Zhou JP, et al. Advances in antidiabetic agents targeted PPAR [J]. Prog Pharm Sci, 2004,28:193-198.
4. Grossman LD. New solutions for type 2 diabetes mellitus [J]. Pharmacoeconomics, 2002,20;1-9.
5. Cantello BCC, Cawthorne MA, Cottam GP, et al. [[o-(Heterocyclylamino) alkoxy]-benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents [J]. J Med Chem, 1994,37:3977-3985.
6. Sauerberg P, Pettersson I, Jeppesen L, et al. Novel tricyclic-α- alkyloxyphenylpropionic acids; dual PPARα/γ agonists with hypolipidemic and antidiabetic activity [J]. J Med Chem, 2002,45:789 -804.
7. Brook DA, Etgen GJ, Rito CJ, et al. Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2-aryloxazol-4-yl) ethoxy]phenoxy}-propionic acids; a new class of dual PPARα/γ agonists [J]. J Med Chem, 2001,44:2061-2064.
8. Henke BR, Blanchard SG, Brackeen MF, et al. N-(2-Benzoylphenyl)-L- tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyper-lipidemic agents [J]. J Med Chem, 1998,41: 5020-5036.
9. Willson TM, Brown PT, Sternbach DD, et al. The PPARs: from orphan receptors to drug discovery [J]. J Med Chem, 2000,43:527-550.
10. Yang G, Gao X, Yan J, et al. Establishment of GOD-POD assay in a minimal way and application to glucose metabiolism of 3T3-L1 adipocyte and HepG2 cell in vitro [J]. Sichuan J Anat, 2003,11; 12-15.
11. Newman MS, Cella JA. Monoalkylation of hydroquinone [J]. J Org Chem, 1974,39:214-215.
12. Davis PD, Elliot LH, Harris W, et al. Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity [J]. J Med Chem, 1992,35:994-1001.